Inspiratory Muscle Training in Children With Beta Thalasemia
NCT ID: NCT06466304
Last Updated: 2024-06-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
40 participants
INTERVENTIONAL
2024-06-06
2024-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Inspiratory Muscle Training in Children With Chest Burn
NCT05603507
Inspiratory Muscle Training and Hospital Complications
NCT02459444
Pulmonary Functions in Sickle Cell Disease: Response to Acu-TENS
NCT06757829
Inspiratory Training in Children After Fontan
NCT06580808
Effectiveness of Inspiratory Muscle Training in Patient With Stable Angina
NCT03923153
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
study group
children patients with BTM accounted 20 children will receive two session per day of training by threshold inspiratory muscle trainer ( for six day per week for 12 weeks). the session will contain six sets of inspiratory muscle training and the one set will contain five respiratory cycles
inspiratory muscle training
children patients with BTM accounted 20 children will receive two session per day of training by threshold inspiratory muscle trainer ( for six day per week for 12 weeks). the session will contain six sets of inspiratory muscle training and the one set will contain five respiratory cycles
control group
children patients with BTM accounted 20 children will receive no trianiing and will serve as control children group
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
inspiratory muscle training
children patients with BTM accounted 20 children will receive two session per day of training by threshold inspiratory muscle trainer ( for six day per week for 12 weeks). the session will contain six sets of inspiratory muscle training and the one set will contain five respiratory cycles
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* boys and girls
Exclusion Criteria
* cardiac diseases renal diseases liver diseases muscle and joint disease
8 Years
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ahram Canadian University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hagar Ahmed El-Hadidy
Physical Therapy for Internal Medicine and Geriatrics
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
hagar el-hadidy, lecturer
Role: PRINCIPAL_INVESTIGATOR
Faculty of Physical Therapy, Ahram Canadian University (ACU), Giza, Egypt
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ahram canadian university
Giza, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P.T -INT-06/2024- 544
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.